Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Sanmai Technologies
Los Altos, California, United States
- Ownership
- Private
- Development stage
- Other
01
Overview
Sanmai Technologies is developing a non-invasive, AI-guided ultrasound neurotherapeutic device for brain health. The first device is currently in clinical trials and is not yet commercially available. Early results focus on safety, efficacy, and accessibility for mental health and neurological indications. No published efficacy outcomes or completed trial results are available as of October 2025.
- Therapeutic areas
- NeurologyPsychiatry
- Modalities
- DeviceNon-pharmacological therapy
- Industry
- Therapeutic Medical Devices
Beyond the preview
Go deeper on Sanmai Technologies.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Sanmai Technologies.